BtuF is the periplasmic binding protein (PBP) for the vitamin B12 transporter
Introduction
The ATP-binding cassette (ABC) transporter superfamily consists of mechanochemically coupled polypeptide complexes in which ATP hydrolysis is coincident with transport of solutes against cellular concentration gradients (1). Members of this family share common structural features that are conserved across the phylogenetic spectrum. The prototypical ABC transporter consists of four subunits, two of which are α-helical transmembrane (TM) domains presumed to determine substrate specificity and trajectory. The other two subunits (the ABC's) are peripherally associated with the cytoplasmic region of the TM domains and mechanically couple ATP hydrolysis to solute translocation (2) . In addition, most bacterial importers employ a periplasmic substrate binding protein (PBP) that delivers the ligand to the extracellular gate of the TM domains. ABC transporters have been linked to a number of human diseases, the most notable of which are cystic fibrosis and tumor multidrug resistance (3).
Structures have previously been reported for several PBP's (4), with the maltose binding protein (MBP) being the most widely studied. MBP is composed of two globular domains joined by a hinge region. One maltose molecule binds at the interface of the globular domains. During binding, these domains undergo a substrate-dependent conformational change, rotating approximately 35º about the hinge region (5) . Other studies suggest that this conformational change transmits a signal to the TM domains of the maltose transporter promoting ATPdependent uptake of maltose across the cytoplasmic membrane (6) . Most other PBP's have a similar molecular architecture to MBP and presumably function using a similar ligand-induced "clamping" mechanism. PBP's of this kind are subdivided into types (called I and II) based upon the topology of their globular domains (7, 8) . However, the structure of the TroA Zn ++ PBP displayed a distinct fold wherein a rigid α-helix connects the two ligand binding domains,
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Vitamin B12 is a large organic cofactor with 93 non-hydrogen atoms that is employed in a diverse array of biochemical reactions ranging from methyl transfers to ribonucleotide reduction (11) . B12 is an essential cofactor in all kingdoms of life, and while some bacteria and archaea have evolved the propensity for its synthesis, most prokaryotes and all eukaryotes contain transport systems to import B12 (12) . The products of B12 biosynthesis are called coenzyme B12 and have either a 5'-deoxyadenosyl group or a methyl group as the axial ligand of the cobalt atom on the catalytic face of the cofactor. The industrial process used to prepare B12 for human consumption results in the replacement of this axial ligand by a cyano group, leading to a species called cyanocobalamin or vitamin B12 (13) . As the biosynthesis of B12 requires approximately 30 enzymatic steps (14) , the benefits of importing externally-synthesized molecules are clear. In E. coli, the transmembrane transport of B12 is carried out by the Btu (B twelve uptake) system composed of BtuB, an outer membrane TonB-dependent transporter (15) , and BtuCDF, an ABC transporter located in the inner membrane. BtuC and BtuD compose respectively the TM domain and the ABC (16), while BtuF is the cognate PBP (17) . The crystal structure of the BtuCD integral membrane protein complex has recently been reported (18) . We herein present the crystal structures of both vitamin B12-bound and free (apo) forms of BtuF.
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Experimental Procedures
Protein expression and purification. Pre-BtuF including its N-terminal signal peptide was cloned into pET24 (Novagen), and periplasmic expression of the mature protein was induced for 4 hours at 37˚ C in E. coli BL21(DE3) cells. A cleared lysate in 300 mM NaCl, 10 mM imidazole, 10% glycerol, 10 mM DTT, 50 mM potassium phosphate, pH 7.0, was loaded on a Ni-NTA SF (Qiagen) column and eluted with a linear gradient to 250 mM imidazole. Following gel filtration on a Superdex 200 column (Pharmacia) in 100 mM NaCl, 10 mM DTT, 10 mM
Tris-Cl, pH 7.5, the protein was concentrated to 10 mg/ml for crystallization. Selenomethionine Crystallization. Crystals were grown using standard 1:1 hanging-drop vapor diffusion reactions.
For the B12 crystals, 5 mM cyanocobalamin (Sigma) was added to the protein stock, and the well solution contained 2.0 M NaCl, 3% ethanol, 100 mM Na-acetate, pH 4.6. Crystals grew to a maximum size of ~200 3 µm over 10 days and were cryoprotected by incubation for 1 hour in the well solution plus 5 mM B12 and 30% glycerol before freezing in liquid propane. Apo crystals grew to a maximum size of ~400 3 µm over one week using a well solution containing 30% PEG 4K, 200 mM (NH 4 )Cl, 100 mM Na-acetate, pH 4.6. They were cryoprotected by incubation for 30 minutes in 40% PEG 4K, 100 mM NH 4 Cl, 10% glycerol, and 50 mM Naacetate, pH 4.6.
X-ray data collection and structure determination. Data were collected at NSLS beamline X12C at Brookhaven National Lab using the Brandeis-B4 detector. Multi-wavelength anomalous diffraction datasets were collected in 365˚ sweeps at 0.9785 Å, 0.9787 Å, and 0.9500 Å using 1º oscillations. Data processing and reduction were performed with DENZO and SCALEPACK (19 Page -6 - (20) , and density modification with automated model building was carried out by RESOLVE (21) . Density modification with NCS averaging in DM (22) allowed completion of this structure, which was use to solve the apo structure by molecular replacement with COMO (23).
Model building, refinement, and molecular graphics. Models were built using O (24) and refined using CNS (25,26) without imposing NCS restraints at any stage. R free sets containing 5% of the reflections were selected at random independently for each crystal form. Refinement comprised iterations of overall anisotropic B-factor refinement, bulk-solvent correction, rigidbody refinement, positional minimization, and individual isotropic B-factor refinement.
Residues in the BtuF models are numbered according to their position in the mature protein, i.e.
after proteolytic cleavage of the 22 residue N-terminal signal peptide in the preprotein.
Coordinates and structure factors for the B12-bound and apo structures have been deposited in the PDB under accession codes 1N4A and 1N4D, respectively. Molecular interactions were analyzed using the program CONTACT from CCP4 (27) using a cut-off of 3.8 Å for van der the B12 ring (Fig. 2B) . The reversal of binding geometry in BtuF may be caused by obstruction of the face that typically interacts with this domain by the DMB moiety in the base-on conformation.
Geometry of Vitamin B12 Binding. The highly conserved (Fig. 3B ) B12 binding site in BtuF is strongly acidic (Fig. 3C) in spite of the fact that the protein molecule as a whole is slightly basic (pI ≈ 7.9). The DMB-binding surface of B12 interacts exclusively with residues in domain I in BtuF, while the catalytic surface interacts exclusively with domain II (Fig. 3A) . In contrast to the type I and II PBP's and TroA, there is significant solvent-exposure of the bound ligand, as also observed in the FhuD complex with gallichrome (33). Nonetheless, approximately 820 Å 2 of the solvent-accessible surface area of the vitamin B12 is buried in the complex, corresponding to 62% of the total. Eleven residues in BtuF (shaded pink in Fig. 1C ) make direct contacts to the bound vitamin B12 (Figs. 3A and 4B ). In addition, 6 residues (shaded green in Fig. 1C ) mediate water-mediated hydrogen bonds (H-bonds) to the ligand that are conserved between the two NCS-related BtuF monomers in the crystal structure (see the green spheres in Fig. 3A) .
A total of 6 residues in domain I make 50 direct contacts to B12 (Figs. 3A and 4B ). The backbone oxygen of ala-10 in helix α1 forms an H-bond to the propionamide nitrogen of Ring A in the corrin, while the sidechains of ser-8 and pro-9 in the same helix make van der Waals contacts to other atoms in the same propionamide group. The sidechain of the phylogeneticallyinvariant residue tyr-28 in strand β2 makes an H-bond to the propionamide oxygen of Ring B, while the sidechain of the phylogenetically-invariant residue trp-63 in strand β4 makes van der Waals contacts to the DMB group. The carbonyl oxygen of the highly conserved residue gly-65 following strand β4 contacts the sugar group of the nucleotide. In Fig. 4A , the B12-bound and apo molecules are aligned by least-squares superposition of their N-terminal domains. As expected, a large conformational change of the type observed in MBP does not occur as it is sterically prohibited by the rigidity of the interdomain helix α6. However, both apo molecules show a rigid body rotation about residue pro-105 at the N-terminus of the interdomain helix, leading to a net displacement of both this helix and domain II compared to the B12-bound structure (Fig. 4A) . The magnitude of this rotation is larger in the "B" molecule (Apo-B) than the "A" molecule (Apo-A), but a similar trajectory of movement is observed in both. In Apo-B, the interdomain helix appears to rotate ~10˚ upward upon ligand release, causing helix α8 and strand β9 in domain II to move slightly outward from the B12-binding site.
The movement of these secondary structural elements leads to a modest ~1 Å expansion of the ligand-binding cavity (Fig. 4A ) that is likely to facilitate ligand exchange. The residue experiencing the largest displacement is pro-132 at the C-terminus of the interdomain helix, which moves ~6 Å in Apo-B. This global conformational change is consistently observed in both apo BtuF molecules and contrasts with the local change observed in the apo structure of TroA (7, 8) , where the release of Zn ++ results in an ~1 Å net movement of the two domains towards one another without any obvious conformational changes in peripheral regions.
Comparing the protein structures within the individual domains, the equilibrium conformation of domain I is tightly conserved in both of the apo BtuF molecules compared to the B12-bound molecules (Fig. 4A) . The backbone B-factors in this domain are also very similar in the apo structures and B12-bound structures, except for a local elevation at two sites in the apo structures corresponding to protein loops that directly contact B12 when it is bound (Fig. 4B ).
In contrast, substantially larger differences are consistently observed in both the equilibrium conformation and backbone B-factors in domain II in the two NCS-related molecules in the apo structure (Fig. 4) . the apo molecules (Fig. 4B) , indicating a global increase in the mobility of domain II upon ligand release. These high B-factors lead to the presence of weak electron density at the corresponding sites in the protein structure. The density is so weak in domain II of the Apo-B molecule that it was not possible to interpret the conformation of residues 195-211. Although the corresponding region could be interpreted in the Apo-A molecule, it has the highest backbone B-factors in this molecule (Fig. 4B) . The least mobile regions in domain II of the apo molecules (ß6, α10, and α11) are those in closest proximity to the interdomain helix, so the entire domain would appear to pivot around this point of attachment. However, there also seems to be an increase in the internal mobility of this domain in the absence of B12 as differences in its equilibrium conformation are observed in both apo molecules in the regions with high backbone B-factors (Fig. 4A) . The largest conformational change occurs in the region of BtuF that has the highest B-factors in the Apo-A molecule (and was uninterpretable in the Apo-B molecule) and involves the unfolding of both termini of helix α9 in the absence of ligand (Fig 4B) . The relatively remote location of these conformational changes compared to the ligand-binding site reinforces the inference that they are coupled to a general increase in the flexibility / mobility of domain II.
The differences in the equilibrium conformation in domain II in the apo structures occur near the surface expected to interact with the BtuCD transporter (lower right in Fig. 4A ) and are thus likely to inhibit the gratuitous binding of apo BtuF to the transporter. Moreover, the consistent increase in the mobility of domain II observed in both of the independently-observed NCSrelated apo molecules suggest that the conformational entropy of domain II increases after the release of B12 into the transmembrane gate, and this effect could help promote dissociation and recycling of apo BtuF (36). (18) contains a B12-sized cavity in the transmembrane region near the periplasmic surface of the transporter at the interface between a pair of BtuC subunits related by 2-fold symmetry.
However, computational analyses show that this cavity is sealed from the periplasm (yellow surface in Fig. 4 of reference (18) Future studies will be required to determine how the asymmetrical vitamin B12 and BtuF molecules bind to the symmetrical BtuCD complex during the active transport reaction.
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